CAS 862690-19-5

Levofloxacin Methyl Ester

Produit contrôlé

CAS : 862690-19-5

Formule : C₁₉H₂₂FN₃O₄

Couleur et forme : Neat

Masse moléculaire : 375.39

Ref: 86-MM0846.06

Levofloxacin Methyl Ester

Produit contrôlé

CAS : 862690-19-5

Formule : C₁₉H₂₂FN₃O₄

Couleur et forme : Neat

Masse moléculaire : 375.39

Ref: TR-L360035

Levofloxacin methyl ester

CAS : 862690-19-5

Levofloxacin methyl ester is an analog of levofloxacin, a fluoroquinolone antibiotic that targets bacterial DNA gyrase and topoisomerase IV. This compound has been found to inhibit kinases in human cancer cells, making it a potential candidate for anticancer therapy. Levofloxacin methyl ester has also been shown to increase the activity of rifampicin against Chinese hamster ovary (CHO) cells, indicating its potential as a synergistic drug combination. In addition, this compound has demonstrated apoptosis-inducing effects on tumor cells and may serve as an inhibitor of cancer cell growth. Levofloxacin methyl ester is excreted in urine and has been shown to have antioxidant properties similar to astaxanthin.

Formule : C₁₉H₂₂FN₃O₄

Degré de pureté : Min. 95%

Masse moléculaire : 375.4 g/mol

Ref: 3D-MJB69019

Levofloxacin Methyl Ester

CAS : 862690-19-5

Formule : C₁₉H₂₂FN₃O₄

Masse moléculaire : 375.39

Ref: ST-EA-CP-L17012